flosz schreef:
[quote=Mr Greenspan]
We hebben nog heel veel in te halen van het afgelopen half jaar.
[/quote]
Precies!
06 April 2006 Crucell announces STAR(TM) Research License Agreement
05 April 2006 Crucell to divest Gräub AG, the veterinary business of Berna Biotech
27 March 2006 Crucell to sell Rhein Biotech GmbH to Dynavax
27 March 2006 Crucell Announces Product Approval in Korea for Quinvaxem(TM) Vaccine
14 March 2006 Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UCB
09 March 2006 Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UMN Pharma
18 Jan. 2006 Crucell and Ark Therapeutics Extend PER.C6® Agreement with Commercial License
11 Jan. 2006 Berna Shareholders Open Door for Combination with Crucell
10 Jan. 2006 Crucell Shareholders Approve Exchange Offer for Berna Biotech
05 Jan. 2006 Crucell Licenses STAR(TM) Technology to XOMA for Research Use
22 Dec. 2005 Contract Manufacturing Agreement Takes PER.C6® into Canada
22 Dec. 2005 Crucell Announces Second PER.C6® Licensing Agreement with Merial
22 Dec. 2005 Crucell and WRAIR Sign CRADA to Evaluate PER.C6® Technology for Development of Flavivirus Vaccines
21 Dec. 2005 Crucell and DSM Announce Second PER.C6® License Agreement with Ferring Pharmaceuticals
21 Dec. 2005 Crucell and DSM Announce PER.C6® Licensing Agreement with ZyStor Therapeutics
20 Dec. 2005 Crucell and DSM further strengthen and expand the development of PER.C6® Protein and Monoclonal Antibody Licensing Business
19 Dec. 2005 Crucell Announces STAR(TM) Licensing Agreement with Genzyme
16 Dec. 2005 Crucell Gains Approval and Moves to Recruitment for West Nile Vaccine Phase I Clinical Study
08 Dec. 2005 Crucell Announces PER.C6® Licensing Agreement with Vakzine Projekt Management
23 Nov. 2005 Crucell Announces PER.C6® Licensing Agreement with Tibotec
02 Nov. 2005 Crucell Teams up with ACE BioSciences and Harvard to Accelerate Bacterial Antibody Program